U.S. markets closed

Four Healthcare Stocks Looking to Close Out a Strong Week

CORAL GABLES, FL / ACCESSWIRE / February 22, 2019 / The healthcare stock market has garnered significant attention over the last few months, as more companies in the industry are working to focus their efforts on developing new treatments for patients suffering from a variety of ailments. Nearly every day, headlines are popping up surrounding these innovative companies in the healthcare industry as they tackle the prevalent need for qualitative care. Whereas other industries may have different core values and purposes, healthcare companies are tasked with keeping consumers healthy and amid that responsibility, if done correctly, lies the potential for lucrative opportunities. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Zosano Pharma Corporation (ZSAN), Achieve Life Sciences Inc (ACHV), and Aurora Cannabis Inc (ACB) represent four healthcare companies focused on the advancement of the global healthcare industry.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a Canadian publicly traded company dead set on rising to the top of the global healthcare market. The Company develops innovative health care approaches that combine expertise from medical professionals at the top of their respective fields with emerging technologies, all with the goal of placing power back in the hands of patients. For too long patients have been at the mercy of their insurance providers and large-scale pharmaceutical companies. As we can see from Premier Health's subsidiary HealthVue Medical, which boasts an ecosystem of over 100,00 active patients, the Company's patient centric model is working.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) provided investors with a corporate update at the tail-end of last week detailing several thresholds the Company crossed over the past couple of months.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) successfully acquired Cloud Practice Inc., a healthcare technology company that provides cloud-based electronic medical records software applications for physicians throughout Canada. Cloud Practice's suite of products includes Juno EMR, a cloud-based EMR solution; ClinicAid, a medical billing software; and MyHealthAccess, an online patient portal. With this acquisition, Premier now has a collective ecosystem of over 3,000,000 active patients and 287 primary care clinics.

In an attempt to focus their expansion efforts into global markets, Premier Health Group (OTC:PHGRF) (CSE:PHGI) recently announced a partnership with a major online healthcare company in China, 360 Health. The parent company, 360 Security Technology, is a leading online service company in China with a market capitalization of over $20 billion USD as of February 14, 2019. This provides an opportunity for our team of health care providers to play an essential role in providing general practitioner training virtually and on site through medical seminars.

For More Information On Premier Health Group, Click Here

Zosano Pharma Corporation (ZSAN) yesterday announced the completion of the second and final goal of the long-term safety study for Qtrypta, in which patients treated migraine attacks over a one year period. The long-term data generated in this trial reinforced the well-tolerated safety profile and strong efficacy results previously reported in the six-month dosing portion of this safety study and in the randomized Phase 2/3 ZOTRIP pivotal study.

Following the announcement, John Walker, chairman, president and CEO of Zosano, said, ''we look forward to continued interactions with the FDA as we prepare to submit a New Drug Application in the fourth quarter of this year for Qtrypta. We believe Qtrypta will be an important alternative for patients whose migraine disease is not well managed with other therapies.''

For More Information on Zosano Pharma Corporation, Click Here

Achieve Life Sciences Inc (ACHV), a clinical-stage biopharmaceutical company committed to the global development of cytisinicline for smoking cessation, today announced final data from their Phase I/II multi-dose, pharmacokinetic and pharmacodynamics (PK/PD) clinical study of cytisinicline in smokers. Per the details of the announcement, the study evaluated the repeat-dose PK and PD effects of 1.5 mg and 3.0 mg cytisinicline in 26 healthy volunteer smokers when administered over the standard 25-day course of treatment.

Dr. Cindy Jacobs, Chief Medical Officer for Achieve, commented, ''given the short 25-day treatment period, the abstinence rates observed are impressive, particularly since subjects were not required to commit to quitting and received minimal behavioral support during the study.''

For More Information On Achieve Life Sciences Inc, Click Here

Aurora Cannabis Inc (ACB) made headlines earlier this week when the Company announced that, effective immediately, Mr, Darren Karasiuk, formerly Executive Vice President Adult Usage, Global, has been promoted to Chief Commercial Officer. Additionally, the Company has promoted, effective immediately, Ms. Jill Swainson, previously Senior Vice President Legal Affairs, to Chief Legal Officer and Corporate Secretary of the Company.

Following the announcement of the Company's new appointments, Terry Booth, CEO of Aurora, said, ''We identified early on that Darren was instrumental in the success that MedReleaf, and now Aurora, has had in the development of well-respected brands which have resonated strongly within both our medical and domestic consumer markets. Jill has worked with our senior leadership team since Aurora was formed, leveraging her extensive experience and legal acumen which has been critical in successfully executing our business strategy.''

For More Information On Aurora Cannabis Inc, Click Here

What Is Stock Price (StockPrice.com)?

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.

StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid ''500,000'' shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the ''500,000'' shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.

Contact Information:


SOURCE: StockPrice.com

View source version on accesswire.com: